To evaluate and compare the pharmacokinetic interactions and safety of multiple dose of Treatment A and Treatment B alone and in combination
The objective of this study was to evaluate pharmacokinetic characteristics and safety after oral concurrent administration of Treatment A and Treatment B compared to each single administration in Healthy volunteers.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
31
Clinical Trial Center, Chungnam National University Hospital
Daejeon, South Korea
The Pharmacokinetics(PK) parameters AUCss,τ
AUCss,τ in a steady-state after multiple-dose (single or combined administration).
Time frame: 0~24 hours
The Pharmacokinetics(PK) parameters Css,max
Css,max in a steady-state after multiple-dose (single or combined administration).
Time frame: 0~24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.